Atomoxetine Hydrochloride

盐酸托莫西汀

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameAtomoxetine Hydrochloride
Drug Alias Name盐酸阿托莫西汀atomoxetinaAtomoxetinumTomoxetine hydrochlorideStrattera +[7] 
ClassificationSmall molecules
Mechanisms of ActionNorepinephrine reuptake inhibitors
TargetsNorepinephrine transporter
Therapy Area/IndicationsDrug intoxicationsSchizophreniaAutistic Disorder +[37] 
Global Approved IndicationsAttention Deficit Disorder with Hyperactivity
Approved Indications in ChinaAttention Deficit Disorder with Hyperactivity
Original Approved Country/TerritoryUnited States
Original Approved Date2002/11/26
Country/TerritoryBelgiumCanadaUnited States +[29] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesRadboud University Medical CenterThe Brigham and Women's HospitalNational Center For Advancing Translational Sciences +[9] 
Inactive CompaniesYale UniversityThe University Of IowaNational Institute On Drug Abuse +[16] 
Active IndicationsAttention Deficit Disorder with HyperactivityAlcoholismObesity +[11] 
Inactive IndicationsDrug intoxicationsSchizophreniaAutistic Disorder +[26] 

Other Information

ATC CodeN06BA09
Related LinksWikipediaDrugBankKEGG